Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (9)

2024

  1. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

    Science Advances, Vol. 10, Núm. 28

2014

  1. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

2011

  1. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

    Hepatology, Vol. 53, Núm. 1, pp. 23-31

2009

  1. Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells

    Journal of Virology, Vol. 83, Núm. 7, pp. 3298-3311

2008

  1. Cells as vehicles for therapeutic genes to treat liver diseases

    Gene Therapy, Vol. 15, Núm. 10, pp. 765-771

2006

  1. Nuevos tratamientos para la hepatitis C

    Medicina Clinica, Vol. 127, Núm. 3, pp. 104-112

2004

  1. MAGE antigens: Therapeutic targets in hepatocellular carcinoma?

    Journal of Hepatology

2003

  1. Leptin expression in the rat ovary depends on estrous cycle

    Journal of Histochemistry and Cytochemistry, Vol. 51, Núm. 10, pp. 1269-1277

2002

  1. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

    Clinical Cancer Research, Vol. 8, Núm. 10, pp. 3219-3225